Vestcor Inc Innoviva, Inc. Transaction History

Vestcor Inc

$3.17 Billion
Q3 2024

A detailed history of Vestcor Inc transactions in Innoviva, Inc. stock. As of the latest transaction made, Vestcor Inc holds 55,413 shares of INVA stock, worth $970,835. This represents 0.03% of its overall portfolio holdings.

Number of Shares

55,413

Previous 55,413 -0.0%

Holding current value

$970,835

Previous $909,000 17.71%

% of portfolio

0.03%

Previous 0.03%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$14.56 - $16.78 $19,335 - $22,283	-1,328 Reduced 2.34%	55,413 $844,000
Q3 2023 Nov 14, 2023	SELL	$12.37 - $13.89 $284 - $319	-23 Reduced 0.04%	56,741 $737,000
Q2 2023 Aug 15, 2023	SELL	$11.39 - $13.72 $38,065 - $45,852	-3,342 Reduced 5.56%	56,764 $723,000
Q1 2023 May 15, 2023	SELL	$10.73 - $13.6 $334,271 - $423,680	-31,153 Reduced 34.14%	60,106 $676,000
Q4 2022 Feb 15, 2023	SELL	$11.8 - $13.78 $1.27 Million - $1.49 Million	-108,017 Reduced 54.2%	91,259 $1.21 Million
Q3 2022 Nov 14, 2022	BUY	$11.61 - $15.22 $10,657 - $13,971	918 Added 0.46%	199,276 $2.31 Million
Q2 2022 Aug 15, 2022	BUY	$14.32 - $19.88 $1.62 Million - $2.25 Million	113,198 Added 132.92%	198,358 $2.93 Million
Q1 2022 May 16, 2022	BUY	$15.39 - $20.25 $109,330 - $143,856	7,104 Added 9.1%	85,160 $1.65 Million
Q4 2021 Feb 15, 2022	BUY	$15.91 - $18.72 $1.12 Million - $1.32 Million	70,571 Added 942.83%	78,056 $1.35 Million
Q1 2021 May 17, 2021	SELL	$11.06 - $12.87 $1.1 Million - $1.28 Million	-99,697 Reduced 93.02%	7,485 $89,000
Q4 2020 Feb 16, 2021	BUY	$9.33 - $12.48 $188,083 - $251,584	20,159 Added 23.17%	107,182 $1.33 Million
Q3 2020 Nov 16, 2020	BUY	$10.33 - $14.49 $196,662 - $275,860	19,038 Added 28.0%	87,023 $909,000
Q2 2020 Aug 14, 2020	BUY	$11.49 - $15.26 $781,147 - $1.04 Million	67,985 New	67,985 $950,000

Others Institutions Holding INVA

# of Institutions

228

Shares Held

78.9M

Call Options Held

37.6K

Put Options Held

300

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.22B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestcor Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vestcor Inc with notifications on news.

Account